These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13984298)

  • 1. [Treatment of caseo-cavernous tuberculosis in children with large doses of INH and small doses of PAS].
    STOJKOV N
    Tuberkuloza; 1962; 14():123-31. PubMed ID: 13984298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical picture of erythema fixum generalisatum caused by PAS hypersensitivity observed in 41-year-old male with pulmonary tuberculosis after a prolonged treatment with antitubercular agents (INH and PAS)].
    Laszczka C
    Gruzlica; 1965 Oct; 33(10):935-7. PubMed ID: 4222649
    [No Abstract]   [Full Text] [Related]  

  • 3. [Directions for the treatment of children with primary pulmonary and hilar lymph node tuberculosis].
    van ZEBEN ; van der DRIFT
    Maandschr Kindergeneeskd; 1963 Jan; 31():3-25. PubMed ID: 14003349
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentration and tolerance of INH and PAS in single daily doses. (Preliminary report)].
    Vil'derman AM; Finn ER; Busygina RN; Draganiuk KA; Ezerskiĭ VF; Evgrafova ZA
    Probl Tuberk; 1965; 43(11):30-4. PubMed ID: 5875728
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of single daily doses of tuberculostatic preparations in extra-pulmonary tuberculosis in children].
    Subbotskiĭ ASh; Audambaeva AI; Bultacheeva LA; Gutevich LV
    Probl Tuberk; 1970; 48(8):64-5. PubMed ID: 5312977
    [No Abstract]   [Full Text] [Related]  

  • 6. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pyrazinamide in association with streptomycin, PAS and isoniazid in the therapy of pulmonary tuberculosis].
    TODOROFF T; FRANZOSI P
    Minerva Med; 1962 Sep; 53():2667-73. PubMed ID: 13985260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Utilization in the treatment of tuberculosis in children of a single daily oral dose of isoniazid and para-aminosalicylic acid].
    Sarrouy C; Viallier J; Vaillaud JC
    Ann Pediatr (Paris); 1967 Mar; 14(3):219-24. PubMed ID: 5614546
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of primary tuberculosis in infants and children].
    Debrè R
    Rev Esp Pediatr; 1965; 21(124):419-32. PubMed ID: 5294953
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous injection of isoniazid and PAS twice weekly to outpatients with tuberculosis in rural areas].
    Ursov IG; Volokitin FN; Borovinskaia TA
    Probl Tuberk; 1983 Nov; (11):42-5. PubMed ID: 6675002
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of isoniazid and PAS on various biochemical indices of liver function in patients with tuberculosis].
    Savula MM; Tytor IaN
    Vrach Delo; 1983 Jul; (7):16-9. PubMed ID: 6624048
    [No Abstract]   [Full Text] [Related]  

  • 13. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
    Tytor IaM
    Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
    [No Abstract]   [Full Text] [Related]  

  • 14. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys].
    Savula MM
    Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of 3 antitubercular therapeutic programs comprising isoniazid with 4,4'-diisoamyloxythiocarbanilide. streptomycin and calcium-benzoyl-PAS].
    FAVEZ G; VULLIEMOZ P; BREAUD P
    Acta Tuberc Pneumol Belg; 1963; 54():103-9. PubMed ID: 14010281
    [No Abstract]   [Full Text] [Related]  

  • 16. [PAS glucoside as an infusion solution in the treatment of cavernous pulmonary tuberculosis and tuberculous meningitis].
    EHLERT H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 112(1):85-90. PubMed ID: 13208540
    [No Abstract]   [Full Text] [Related]  

  • 17. [INH-induced pellagra in pulmonary tuberculosis].
    Sönnichsen N; Zoellner E; Randow U
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):224-7. PubMed ID: 5899146
    [No Abstract]   [Full Text] [Related]  

  • 18. [TREATMENT OF PULMONARY TUBERCULOSIS WITH LARGE DOSES OF INH].
    DELOFF L; GRZESKOWSKI J; MICHALIK M; OKLEK K
    Gruzlica (1926); 1963 Mar; 31():201-6. PubMed ID: 14060343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RESULTS OF THE TREATMENT OF RECENT PULMONARY TUBERCULOSIS WITH LARGE DOSES OF INH].
    KOCHNOWSKI G
    Gruzlica (1926); 1963 Mar; 31():263-6. PubMed ID: 14060351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.